2001). Evidence for this was the observation that, although cADPR and caffeine each increased Ca 2+ spark frequency in cardiac myocytes, the onset of cADPR's effect was significantly later (>2 minutes) than that of caffeine. This delay was attributed to the time required for the SR Ca 2+ content to be increased following SERCA activation by cADPR (Lukyanenko et al., 2001) . This proposal could explain the frequently observed pronounced delay in the onset of cADPR activity (Cui et al., 1999; Aarhus et al., 1995; Li et al., 2000) .
However, despite the evidence that supports a role for cADPR in Ca 2+ release by modulating RyR activity either directly or indirectly, controversy persists regarding receptor involvement. This dispute has been sustained by the apparent failure of cADPR itself to contract tracheal and intestinal smooth muscle (Iizuka et al., 1998; Kuemmerle and Makhlouf, 1995) , to modify the contraction induced by carbachol in tracheal smooth muscle (Iizuka et al., 1998) , or indeed to activate RyR at all (Copello et al., 2001; Lukyanenko et al., 2001) . Our interest in the mode of action of cADPR, in the light of this controversy, has led us to re-examine its effects and mechanisms on smooth muscle, in order to assess its role in Ca 2+ signalling. We chose a cell type with RyR known to contribute to its physiological responses -colonic myocytes . The investigation was particularly concerned to establish whether, in smooth muscle, cADPR regulated the release of Ca 2+ via RyR and, if so, whether receptor involvement took place directly or indirectly via intermediaries such as FKBPs. To avoid changes in Ca 2+ influx and therefore in [Ca 2+ ]c brought about by changes in membrane potential (e.g. Petersen and Cancela, 1999) , single voltageclamped myocytes were used. Photolysis of caged cADPR was used to increase cADPR concentrations rapidly and directly.
This study has shown that cADPR failed to increase either bulk average or subsarcolemma [Ca 2+ ] in smooth muscle, nor did it induce CICR. By contrast, the RyR activator caffeine altered both bulk average and subsarcolemma [Ca 2+ ] and induced CICR. FKBP12.6, a proposed receptor for cAPDR (Noguchi et al., 1997) , was absent from the myocytes. The introduction of recombinant FKBP12.6 as substitute reduced SR Ca 2+ release but, in its presence, cADPR remained ineffective. In contrast to the absence of any direct or indirect effects on RyR, cADPR accelerated and a cADPR antagonist slowed the rate of Ca 2+ removal from the cytoplasm. Thus, in an intact cell with RyR, cADPR might not affect Ca 2+ release directly but might modulate [Ca 2+ ]c via Ca 2+ removal.
Materials and Methods

Materials
Caged cADPR, fluo-3 AM ester and fura-2-conjugated dextran were purchased from Molecular Probes (Cambridge Bioscience, Cambridge, UK); caged inositol (1, 4, 5) triphosphate [Ins(1, 4, 5 )P3] trisodium salt, cADPR, thapsigargin and fluo-3 penta-ammonium salt from Calbiochem-Novabiochem (Nottingham, UK). FK506 was gifted by Fujisawa (München, Germany). Coomassie Plus Protein Assay Reagent was purchased from Perbio (Cheshire, UK). All other reagents were from Sigma (Poole, UK).
Colonic myocytes
Cell dissociation Single myocytes were enzymatically dissociated (McCarron and Muir, 1999 ) from colonic muscle from male guinea pigs (550-750 g), humanely killed by cervical dislocation and exsanguination in accordance with the guidelines of the UK Animal (Scientific Procedures) Act (1986) .
Solutions
The extracellular solution contained 80 mM sodium glutamate, 40 mM NaCl, 20 mM tetraethylammonium chloride (TEA), 1.1 mM MgCl2, 3 mM CaCl2, 10 mM Hepes and 30 mM glucose (pH 7.4 with NaOH). The Na + -free bathing solution was the same with LiCl replacing Na + salts (pH 7.4 with LiOH). The pipette solution contained 85 mM Cs2SO4, 20 mM CsCl, 1 mM MgCl2, 30 mM Hepes, 3 mM MgATP, 2.5 mM pyruvic acid, 2.5 mM malic acid, 1 mM NaH2PO4, 5 mM creatine phosphate, 0.5 mM guanosine phosphate, 0.1 mM fluo-3 penta-ammonium salt and either 0.025 mM caged inositol trisphosphate (InsP3) trisodium salt or 0.05 mM or 0.5 mM caged cyclic adenosine 5′-diphosphate ribose (cADPR). Where spontaneous transient outward currents (STOCs) were measured, the extracellular solution contained 60 mM NaCl and 4.7 mM KCl; TEA was omitted. In the pipette solution, Cs2SO4 and CsCl were replaced by 105 mM KCl. In controls, to determine whether FKBP12.6 could enter the cell via the patch pipette, caged compounds and fluo-3 were omitted and 0.035 mM fura-2-conjugated dextran potassium salt (10 kDa; a fluorescence indicator of comparable weight to that of FKBP12.6) included to estimate the time course of entry of FKBP12.6. Cell fluorescence from the fura-2-conjugated dextran following excitation at the fura-2 isosbestic point (360 nm; the [Ca 2+ ]-independent wavelength) increased to 50% of the final value in 673±175 seconds. These results establish the time course by which the high molecular weight compounds (such as recombinant FKBP12.6) could enter the cell via the patch pipette.
Current recordings
Whole cell currents were amplified by an Axopatch 1D (Axon Instruments, Union City, CA), low pass filtered at 500 Hz (eight-pole Bessel filter; Frequency Devices, Haverhill, MA) and digitally sampled at 1.5 kHz using a Digidata interface, pCLAMP software (version 6.0.1, Axon Instruments) and Axotape (Axon Instruments) and stored on a PC for analysis.
Ca 2+ measurements [Ca 2+ ]c was measured using either a microfluorimeter system (McCarron et al., 1999; Flynn et al., 2001) or a wide-field digital imaging system. Briefly, single cells were illuminated at 488 nm (bandpass 9 nm) from a monochromator and imaged through a Nikon 40×, 1.3 numerical aperture, oil-immersion objective. Ca 2+ images were captured using an intensified, cooled, frame-transfer CCD camera (Pentamax Gen IV) in virtual chip mode with WinView32 (Roper Scientific, Marlow, Buckinghamshire, UK). Images (160×160 pixels), with a pixel size of 563×563 nm at the cell, were acquired at 100 frames second -1 . Imaging and electrophysiology data were synchronized on pClamp by recording a transistor-transistor logic (TTL) output from the CCD camera, reporting the camera's readout status, with the electrophysiology data. In imaging experiments, cells were incubated with 1 µM fluo-3 AM ester and 10 µM wortmannin (to minimize contraction) for 30 minutes (20±2°C) and fluo-3 omitted from the pipette solution.
Fluorescence signals were expressed as ratios (F/F0 or ∆F/F0) of fluorescence counts (F) relative to baseline (control) values (taken as 1) before stimulation (F0). Where the fluo-3 signals were converted into [Ca 2+ ]c (nM), the Kd for fluo-3 was taken as 390 nM, Fmin was assumed to be 0 and Fmax was determined from in vivo calibrations (Cannell et al., 1994) . Image data analyses were performed using the program Metamorph (Roper Scientific, Marlow, Buckinghamshire, cADPR regulation of Ca 2+ removal UK). Experiments on the colonic cells were carried out at either room temperature (20±2°C) or at 35±2°C, as indicated in the text; those on sea urchin eggs at 16°C.
A rise in [Ca 2+ ]c was obtained (1) by depolarizing the membrane from a holding potential of -70 mV to either 0 mV or +10 mV, (2) using 10 mM caffeine [applied by pressure ejection for 3 seconds using a PV820 Pneumatic Picopump (WPI, Hertfordshire, UK)] or (3) by the photorelease of caged InsP3. Submaximal responses to maximal concentrations of caffeine (10 mM) were obtained by increasing the distance of the ejection pipette from the cell. Quantitative differences between maximal and submaximal responses to caffeine were confirmed in each experiment. In the case of STOCs the membrane potential was held over the range -30 mV to 0 mV.
To photolyse caged InsP3 or caged cADPR the output of a xenon flash lamp (Rapp Optoelektronik, Hamburg, Germany) was passed through a UG-5 filter to select ultraviolet light and merged into the excitation light path of the microscope using a quartz bifurcated fibre optic bundle (McCarron and Muir, 1999) . The concentration of the caged, non-photolysed compound given in brackets in the text refers to that in the pipette rather than to that released in the cytosol by photolysis.
Analysis of STOCs
Owing to their variability in amplitude, duration and frequency, STOC activity was summarized by analysing the area under the curve (AUC) of a randomly selected 5-second or 100-second period of STOC discharge under control and test conditions (expressed as picocoulombs, pC). For calculation of the probability of a STOC occurring (PSTOC), the threshold for STOC activity was set at two and a half times the baseline noise value.
'Calculated' and 'measured' increase in [Ca 2+ ]c produced by ICa The increase in [Ca 2+ ]c, as indicated by fluo-3, is termed the 'measured' Ca 2+ . The 'calculated' [Ca 2+ ]c was determined from Ca 2+ current amplitude (ICa) measurement using the following equation: ͐ -ICadt/2FV, where ͐ -ICadt is total charge entry, F the Faraday constant and V the cell volume. ICa was integrated by measuring the area under the curve with reference to the current level obtained after complete block of ICa with 1 mM cadmium chloride. The cell volume was 2 picolitres 2+ ]c measurements, the decline was smoothed by fitting polynomials (fourth to seventh order, selected by the highest r 2 value, where r 2 is the coefficient of determination and represents the strength of linearity in a given relationship. It is usually taken as a measure of goodness of fit) to the data obtained. The derivative was obtained by averaging the slopes of two adjacent data points.
Electrophoresis and immunoblotting
Freshly isolated guinea pig brain and colon in 3 ml buffer [0.9% NaCl, 0.3 M sucrose, pH 7.2, protease inhibitor cocktail (Roche Diagnostics, East Sussex, UK)] per gram of tissue were homogenized using an Ultraturrax three times for 15 seconds each at 4°C. The homogenate's protein content was assayed (using Coomassie Plus Protein Assay Reagent) and preparations resuspended at 4 mg ml -1 total protein. In some experiments, homogenates were treated with either 20 µM FK506 or 50 µM cADPR for 30 minutes at 37°C, followed by centrifugation at 54,000 g for 15 minutes at 4°C. Pellets were resuspended at 2.5 mg ml -1 in 4× Laemmli buffer (NuPage LDS sample buffer; Invitrogen, Grönigen, The Netherlands) with 5 mM dithiothreitol and assayed for FKBP12 by immunoblotting.
Western blotting and protein quantification SDS-PAGE and immunoblotting were performed (Currie and Smith, 1999) using the NuPAGE system (Invitrogen, Grönigen, The Netherlands) with 12% Bis-Tris gels and MES running buffer for FKBP12 detection, using recombinant FKBP12 and/or FKBP12.6 as controls. Blots were incubated with either rabbit anti-FKBP12/12.6 antiserum (SA168) or goat polyclonal anti-FKBP12 (c-19; Santa Cruz Biotechnology, CA), each diluted 1:500. Membranes were then washed and incubated with either goat anti-rabbit IgG coupled to horseradish peroxidase (HRP) or donkey anti-goat coupled to HRP, respectively, both at 1:10,000 dilution. Blots were developed using the ECL detection system (Amersham, Buckinghamshire, UK).
FKBP12 protein abundance was quantified by scanning developed films on a calibrated GS-170 scanner (BioRad, Hertfordshire, UK). Films contained known amounts of total protein and recombinant FKBP12 as a normalization standard. Densitometry volumetric analysis of individual bands was carried out using Quantity One software (BioRad, Hertfordshire, UK).
Sea urchin eggs
Sea urchins (Psammechinus; University Marine Biological Station, Isle of Cumbrae, UK) were placed in artificial sea water at 16°C that contained 430 mM NaCl, 27 mM MgCl2, 28 mM MgSO4, 10 mM CaCl2, 10 mM KCl, 2.5 mM NaHCO3, 1 mM EDTA (pH adjusted to 8 with NaOH). Eggs were released by intracoelomic injection of 0.5 M KCl, passed three to four times through nylon mesh (pore size 130 µm, 47% open area; Plastok, Birkenhead, UK), placed on poly-Llysine-coated (0.02 mg ml -1 ) glass coverslips and immersed in artificial seawater. 250 µM fluo-3 and 1 mM caged cADPR in buffer [20 mM Pipes, 500 mM KCl, 0.1 mM EGTA (pH 6.7 with KOH)] were microinjected into the eggs (Gillot and Whitaker, 1994) . The injected volume was estimated from bubbles of air created by pressure ejection into a chamber of hydrated oil [immersion oil type DF (Nikon, Kingston-upon-Thames, UK)] from a method modified from that of Moore et al. (Moore et al., 1990) . (The volume of the bubble was estimated by measuring its radius and assuming it to be spherical.) The maximum injected volume was calculated to be ~2% of the egg volume, so the final concentration of caged cADPR inside the egg was ~22 µM, comparable to that used in the smooth muscle cells. Experiments were performed at 16°C.
Statistical analysis
Results are expressed as means±SEM of n cells and a Student's t test (paired and unpaired as appropriate) applied to test and control conditions; P<0.05 was considered to be significant. Microsoft ® Excel ® statistical software was used with either t tests or one-way ANOVA with post hoc t test. Fig. 1Aa ) and by photolysis of caged 25 µM InsP3 (∆F/F0=1.5±0.1, n=9, P<0.001; Fig. 1Ab ) (McCarron et al., 2000) . By contrast, photolysis of 50 µM caged cADPR did not increase [Ca 2+ ]c (∆F/F0=0.1±0.0, n=9, P>0.05; Fig. 1Bb ), although depolarization (-70 mV to +10 mV, ∆F/F0=0.8±0.2, n=9, P<0.01, ICa=-109±38 pA; Fig. 1Ba ) and 10 mM caffeine (∆F/F0=1.8±0.5, n=9, P<0.01; Fig. 1Bc ) were each effective. Photolysis of a tenfold increase in the concentration to 500 µM cADPR was no more effective (∆F/F0=0.0±0.01, n=4, P>0.05), although again depolarization (-70 mV to 0 mV, ∆F/F0=0.8±0.2, n=4, P<0.05) and 10 mM caffeine (∆F/F0=1.4±0.3, n=4, P<0.05) each increased F/F0 (data not shown). As a control, to ensure the efficacy of the caged cADPR, the ability of the photolysed compound to release Ca 2+ in sea urchin eggs (a cell type in which cADPR's ability to modulate RyR is agreed) (Galione et al., 1991; Lee et al., 1993) was confirmed ( Fig. 2 ; ∆F/F0=3.1±0.9, n=10, P<0.01; time to peak 14±3 seconds).
Results
Effects
Calmodulin dependence of cADPR-mediated Ca 2+ release from the SR The ability of cADPR to release Ca 2+ from the SR is dependent on calmodulin (Lee et al., 1994) . To determine whether the inability of cADPR to release Ca 2+ from the SR in colonic myocytes was due to a low cytosolic concentration of calmodulin, the contractile response (also dependent on calmodulin) (Stull et al., 1988) following depolarization or photolysis of caged cADPR was measured. 50 µM cADPR again failed to increase [Ca 2+ ]c ( Fig. 3C ; n=9, P>0.05) or contract the myocytes ( By contrast, CICR was induced by a recognized activator of RyR. Caffeine (500-750 µM, added to the bath 3 minutes beforehand) increased the Ca 2+ transient evoked by depolarization (-70 mV to +10 mV) to 168±40% of control (172±35 nM before and 237±47 nM with caffeine, n=10, P<0.01; Fig. 5A ). Upon washout of the drug, the depolarization-evoked response returned towards control 126±8% (177±43 nM, n=6). That caffeine indeed induced CICR following depolarization was confirmed when the relationship between the amount of Ca 2+ entering the cell [i.e. the 'calculated' Ca 2+ increase from the integral of ICa (see Materials and Methods)] and the 'measured' increase in [Ca 2+ ]c (as demonstrated by the change in fluorescence of fluo-3) were compared. 100 milliseconds after the start of the depolarization, the ratio of 'calculated' to 'measured' [Ca 2+ ]c was 424±143 without caffeine ( Fig. 5Di ) and 163±51 in caffeine ( Fig. 5Dii; n=10, P<0.05) . Following washout, the ratio returned towards control (266±74, Fig. 5Diii ). The decreased relationship (see above) between the 'calculated' and 'measured' Ca 2+ increases, in caffeine, suggests that a release of Ca 2+ occurred from the SR subsequent to ICa (i.e. CICR).
Temperature dependence and cADPR activity
The ability of cADPR to release Ca 2+ in cardiac myocytes is reportedly temperature dependent (Iino et al., 1997) . Accordingly, the effects of cADPR in the present study were re-examined at 35±2°C. cADPR again failed to change [Ca 2+ ]c (∆F/F0=0.0±0.0, n=7, P>0.05). Increases in [Ca 2+ ]c were, however, produced each by depolarization (-70 mV to +10 mV; ∆F/F0=1.7±0.4, n=7, P<0.05) and by caffeine (∆F/F0=1.7±0.7, n=7, P<0.05) at 35°C, but these depolarization-evoked increases were unaffected by cADPR when it was photolysed at different time points beforehand (Table 3) . When photolyzed up to 10 seconds prior to depolarisation, cADPR failed to significantly change the rate of Ca 2+ removal from the cytosol (dCa/dt) but did so when photolyzed 15 seconds beforehand. In the analysis, dCa/dt measurement is that at a [Ca 2+ ]c of 225 nM (see also Fig. 9 ). *P<0.05. (Fig. 7) . STOCs arise by the activity of Ca 2+ -activated K + channels on the sarcolemma that have been activated by the local subsarcolemma [Ca 2+ ] increases from the SR via RyR (Benham and Bolton, 1986) . STOCs thus provide an indirect measure of the local subsarcolemma [Ca 2+ ] generated by RyR activity. The area under the curve of the STOC current trace (IKCa) was calculated over a 5-second period and used as a measure of STOC activity in the presence and absence of cADPR. The probability of a STOC occurring (PSTOC) was also determined before and after photolysis of caged cADPR (Fig. 7vi) . This analysis showed that photolysis of cADPR had no significant effect on the frequency or amplitude of STOCs (AUC before 199±82 pC and 184±57 pC after cADPR, n=8, P>0.05, Fig. 7i,ii) or the probability of a STOC occurring over a longer time period (~2.5 minutes). Caffeine, by depleting the SR of Ca 2+ , significantly reduced both the amplitude and frequency of STOCs (AUC before 227±109 pC and -489±371 pC after caffeine, n=5, P<0.05, There was a greater increase in the 'measured' Ca 2+ value for a similar 'calculated' Ca 2+ value in caffeine than in its absence (control). Caffeine removal partially restored the relationship between the 'calculated' and 'measured' increases in [Ca 2+ ]c. A-D are components of the same experiment. These results show that these concentrations of caffeine cause CICR after depolarization-evoked ICa. cADPR regulation of Ca 2+ removal Fig. 7i ,ii). STOCs recovered following caffeine removal (AUC 59±32 pC, P>0.05, n=4).
8-bromo cADPR and Ca 2+ transients evoked by depolarization, caffeine or InsP3
The inability of photolysed cADPR to modify the release of Ca 2+ from the SR might be due to high endogenous levels of cADPR, which could have already maximally enhanced the sensitivity of RyR or another intracellular moiety, to Ca 2+ . If so the inhibition of endogenous cADPR by a selective antagonist (8-bromo cADPR) 
FKBP12.6 as possible cADPR binding sites
Another reason for the lack of activity of cADPR could have been the absence of an appropriate binding site for the compound on RyR (i.e. FKBP12.6) (Noguchi et al., 1997; Tang et al., 2002) . To confirm the presence of FKBP12.6, increasing protein loads from guinea-pig colon and brain (control) homogenates were examined by immunoblotting. Antiserum SA168 detected both FKBP12 and FKBP12.6, whereas the antibody c-19 was more sensitive to FKBP12 than to FKBP12.6. Strong bands corresponding to FKBP12/FKBP12.6 in brain (Fig. 8Ai,ii) were identified. In colon, however, they were absent or very weak (Fig. 8Ai ) and more clearly detected using the antibody c-19 (Fig. 8Aii) than with the antiserum SA168, suggesting that little ]c and evoked a transient outward current after which STOCs were suppressed, presumably as a result of store depletion (iii). There was no change in the probability of a STOC occurring (PSTOC; vi) before (100 seconds) and after (150 seconds) cADPR (vi; n=7; P>0.05).
FKBP12
.6 was present and that FKBP12 was the major FKBP. If FKBP12.6 acted as the receptor for cADPR to modulate RyR opening (Noguchi et al., 1997; Tang et al., 2002) , the absence of the protein (FKBP12.6), in colonic myocytes, might account for the lack of cADPR activity. To explore this possibility, recombinant FKBP12.6 was introduced into the myocytes to compensate for its absence (using the whole cell patch electrode) and the effect of cADPR on RyR mediated Ca 2+ release, as assessed by the occurrence of STOCs, was reexamined (Fig. 8B) . The frequency and amplitude of STOCs were significantly reduced by FKBP12.6 alone (AUC over a 100-second period was 12±4 nanocoulombs (nC) 100 seconds and 4±2 nC 700 seconds after the start of recording, n=5, P<0.05, not significantly different (AUC over 100-second period was 18±5 nC 100 seconds and 13±3 nC 700 seconds after the start of recording, n=7, P>0.05, Fig. 8C ). cADPR in the presence of FKBP12.6 failed to alter STOCs (Fig. 8Bi , over a 5 second period AUC was 256±113 pC in control and 290±93 pC after cADPR) or [Ca 2+ ]c (Fig. 8Bii) . These results suggest that, in the presence of FKBP12.6, cADPR remained ineffective in modulating Ca 2+ release and raise the question of whether or not cADPR binds to FKBP12.6.
To investigate whether cADPR binds to FKBP12.6, brain homogenates were used as a source of the protein, which was largely absent from colonic myocytes. FK506 binds to both FKBP12 and FKBP12.6 (Marks, 1996) , and served as a positive control for the cADPR binding experiments. Densitometric analysis on FKBP12/FKBP12.6 in membrane fractions were performed on samples treated with either FK506 or cADPR. FK506 significantly reduced (by 45%) the FKBP12/FKBP12.6 detected in the membrane fraction (n=4; P<0.05) confirming the adequacy of detection of binding by the densitometric analysis. However, cADPR did not alter the FKBP12/FKBP12.6 detected (Fig. 8Di,ii, P>0.05, n=3) , suggesting that cADPR does not bind significantly to FKBP12 or FKBP12.6.
Effect of cADPR on [Ca 2+ ]c decline
The rate of Ca 2+ removal from the cell increased with increasing [Ca 2+ ]c (i.e. the substrate), which is typical of many enzyme-substrate reactions. This rate was accelerated when free cADPR was introduced into the cell (using the access afforded by the whole cell electrode) over a [Ca 2+ ]c range of 275-450 nM (Fig. 9A ). For example, at 350 nM [Ca 2+ ]c, the rate of decline was 80±6 nM second -1 (control; n=25) and 120±16 nM second -1 in 300 µM cADPR (n=7; P<0.01). In this series of experiments, the peak [Ca 2+ ]c values during the depolarization (1.2±0.1 ∆F/F0 in control and 1.4±0.3 ∆F/F0 in cADPR; P>0.05) were not different. However, 50 µM cADPR photolysed up to 15 seconds beforehand had no effect on the rate of Ca 2+ removal following depolarization (-70 mV to 0 mV) at either 20±2°C or 35±2°C. At a higher concentration (500 µM), cADPR also failed to affect the rate of Ca 2+ removal when photolysed up to 10 seconds before depolarization but significantly increased the rate when photolysed 15 seconds beforehand (P<0.05; Table 2 ), a time consistent with the delays inherent in cADPR effects (e.g. Cui et al., 1999) ; the reason for the delay is not understood.
The [Ca 2+ ]c range over which cADPR increased the rate of decline suggested an acceleration of plasma membrane Ca 2+ pump activity . To examine the effects of cADPR itself on the plasma membrane Ca 2+ pump, the rates of Ca 2+ removal in cADPR had subtracted from it, the control rate (i.e. with all removal mechanisms operative) minus those removal rates occurring after inhibiting mitochondria [by carbonyl cyanide m-chlorophenyl hydrazone (CCCP) and oligomycin together, each 5 µM], the SR Ca 2+ pump (500 nM thapsigargin) and the Na + -Ca 2+ exchanger (Na + -free bathing solution) to yield an inferred plasma membrane Ca 2+ pump The sarcolemma Ca 2+ pump activity was obtained by inhibiting removal occurring via mitochondria, SR and Na + -Ca 2+ exchange. By subtracting from the rates of decline in cADPR, the rates in control (minus those occurring when removal by mitochondria, SR and Na + -Ca 2+ exchange were inhibited), an inferred Ca 2+ pump rate was obtained. This was increased by cADPR (*P<0.05; **P<0.01).
activity in cADPR (Fig. 9B) . The inferred pump activity in cADPR was substantially increased. For example, at 300 nM [Ca 2+ ]c, the inferred plasma membrane Ca 2+ pump rate was 47±8 nM second -1 in the control, and this increased to 82±16 nM second -1 in cADPR.
Although cADPR itself increased the rate of Ca 2+ removal from the cytosol the antagonist 8-bromo cADPR (20 µM) slowed it significantly following photolysed InsP3- (Fig. 10Aa) or depolarization-(Fig. 10Ab) evoked increases. For example, at 225 nM [Ca 2+ ]c (evoked by InsP3) the rate of Ca 2+ removal was 108±13 nM second -1 in controls but was reduced by 8-bromo cADPR to 71±12 nM second -1 (n=8, P<0.01).
Similarly, following a depolarization-evoked increase, the rate of removal in controls was 39±7 nM second -1 and 23±7 nM second -1 in 8-bromo cADPR the effects of 8-bromo cADPR on the sarcolemma Ca 2+ pump were examined when the other removal mechanisms (mitochondria, SR Ca 2+ pump and Na + -Ca 2+ exchanger) had been inhibited. CCCP, oligomycin, thapsigargin and a Na + -free bathing solution together significantly slowed the rate of Ca 2+ removal (Fig. 10Ba,b (Bolton et al., 1999; Sanders, 2001; GuerreroHernandez et al., 2002 . RyR might thus play an important role in excitation-contraction coupling in colonic smooth muscle . Among substances proposed as RyR regulators, cADPR is of particular interest and has been found to be a potent mobilizer of intracellular Ca 2+ in several invertebrate and vertebrate cell types (Lee, 2001 ). Yet there is a controversial literature pertaining to cADPR and Ca 2+ release. On the one hand, several investigations have demonstrated that cADPR can increase Ca 2+ release by a process involving RyR either directly (Galione and Sethi, 1996; Petersen and Cancela, 1999) or via intermediaries (Noguchi et al., 1997; Lee, 2001) . On the other hand, other investigators have failed to repeat these observations (Nixon et al., 1994; Iizuka et al., 1998; Copello et al., 2001; Lukyanenko et al., 2001 ) and argued that RyR activity is not affected by cADPR, observations that might reflect tissue-or species-specific differences.
Against this background of controversy, the present results have provided evidence that cADPR does not directly increase Ca 2+ release in colonic myocytes. This view is supported by several observations. First, as a positive control, caffeine (which activates RyR to release Ca 2+ ) was used to establish the consequences of RyR activity on [Ca 2+ ]c. Three separate effects of caffeine on Ca 2+ homeostasis were identified: (1) (Nixon et al., 1994) smooth muscle respond to cADPR. Negative findings with cADPR on cardiac myocytes have also been reported (Guo et al., 1996; Lukyanenko et al., 2001 ) (G. Smith, personal communication), in contrast to those mentioned in the introduction.
Some reconciliation of the differences in the results with cADPR in cardiac myocytes may be found in the different temperatures at which the experiments were conducted (Guo et al., 1996; Iino et al., 1997) . At 36°C (Iino et al., 1997) , but not at room temperature (Guo et al., 1996) , cADPR was suggested to be effective in modulating Ca 2+ release. However, cADPR failed to alter the activity of RyR1 and RyR2 derived from mammalian striated muscle at both room temperature and 37°C, as measured by their activity in planar bilayers or in SR microsomes, or the binding of [ 32 P]cADPR to the microsomes (Copello et al., 2001) . Differences between the present findings in smooth muscle and those in the heart (Iino et al., 1997) are unlikely to be due to the effects of temperature. cADPR was ineffective in increasing bulk average [Ca 2+ ]c or inducing CICR at either 35°C or room temperature. The effectiveness of cADPR in raising [Ca 2+ ]c in sea urchin eggs at 16°C was confirmed in the present study.
An alternative reason for the failure of cADPR to modulate RyR activity in colonic myocytes is that, although RyR has been demonstrated to be a target for cADPR in some cell types, RyR itself might not, in others, respond directly to cADPR (Fruen et al., 1994; Copello et al., 2001; Lukyanenko et al., 2001) , or its effects might be prevented by the normal ATP or glucose concentrations within cells (Sitsapesan et al., 1994; Cancela et al., 1998) . In some tissues cADPR might release Ca 2+ by a pathway which involves atypical RyR or does not involve RyR at all. For example, the release of Ca 2+ by cADPR was not prevented by depletion of the caffeine-sensitive store or by conventional RyR antagonists, and was inhibited by the InsP3 receptor blocker heparin (Morrissette et al., 1993; Thorn et al., 1994; Kannan et al., 1996; Lahouratate et al., 1997; Prakash et al., 2000) . Indeed cADPR might interact with all isoforms of the InsP3 receptor, stimulate InsP3 binding to the type 1 InsP3 receptor (Vanlingen et al., 2001) or inhibit InsP3-mediated Ca 2+ release (Missiaen et al., 1998) .
Together, these studies present a complicated picture of cADPR's relationship with RyR. This led us to investigate the role of a proposed intermediary between cADPR and RyR. FKBP12.6, a protein reportedly linked to RyR2 and RyR3 in some studies, might act as a receptor for cADPR (Noguchi et al., 1997) . FKBP12.6 might, by interacting with RyR, suppress Ca 2+ release (Prestle et al., 2001; Xin et al., 2002) and the suppression might be relieved by cADPR. Yet FKBPs (12 and 12.6) are not present in all tissues. For example, in the present study [as in humans (Baughman et al., 1997) ], FKBP12.6 was present in brain but not colonic myocytes. It might be argued that, given the lack of effect of cADPR on Ca 2+ signalling, the absence of FKBP accords with the proposal that the protein was a necessary receptor for cADPR. However, this would be incorrect. After the introduction of recombinant FKBP12.6, to compensate for its absence in colonic myocytes, cADPR remained ineffective in modulating Ca 2+ release from the SR and supports the view that cADPR does not modulate RyR activity via FKBP12.6. cADPR, furthermore, did not reduce the immunoblot signal detected by the antiserum to FKBPs in brain, whereas FK506 was effective, suggesting that cADPR might not bind to the FKBPs present (see also Bultynck et al., 2001b) .
Another possible explanation for the lack of cADPR activity on Ca 2+ release could have been a shortage of calmodulin (Lee et al., 1994) , an essential intermediary for smooth muscle contraction (Stull et al., 1988) . The present study showed this to be unlikely: repetitive contractile responses to depolarization-evoked increases in [Ca 2+ ]c, consistent with the presence of calmodulin in myocytes, were obtained routinely. cADPR, furthermore, remained ineffective following dialysis of calmodulin into the myocytes at concentrations similar to those which supported activity in other cells (Lee et al., 1994) .
In contrast to the ineffectiveness of cADPR and its antagonist 8-bromo-cADPR on Ca 2+ release, the compounds were surprisingly effective at modulating Ca 2+ removal mechanisms -cADPR increased and 8-bromo-cADPR reduced the rate of Ca 2+ removal. The antagonist also evoked a steadystate rise in [Ca 2+ ]c, an effect that requires an altered flux of the ion across the sarcolemma (because the SR has finite capacity). Because ICa -the major influx pathway -was inhibited, a decreased removal of Ca 2+ across the sarcolemma by the antagonist might account for the rise in [Ca 2+ ]c. Neither a decrease in steady-state [Ca 2+ ]c nor an increase in SR Ca 2+ content with cADPR was observed, presumably because of the labile nature of the compound after its photorelease. Pharmacological removal of mitochondria, SR Ca 2+ pump and Na + -Ca 2+ exchange activities, leaving the plasma membrane Ca 2+ pump as the only operative Ca 2+ removal mechanism, enabled 8-bromo-cADPR to increase baseline [Ca 2+ ]c and to slow the rate of Ca 2+ removal substantially. This suggests that 8-bromo-cADPR inhibited the plasma membrane Ca 2+ pump. Indeed, indirect evidence of involvement of the plasma membrane Ca 2+ pump in cADPR's acceleration of [Ca 2+ ]c decline was the observations made of the inferred plasma membrane Ca 2+ pump activity. The inferred plasma membrane Ca 2+ pump activity in cADPR was obtained by subtracting from the rate of removal in cADPR the rate of removal in control (i.e. with all removal mechanisms operative) minus the rate obtained after Ca 2+ removal by mitochondria, SR Ca 2+ pump and Na + -Ca 2+ exchange activity had been inhibited (i.e. leaving only plasma membrane Ca 2+ pump operative; not shown). The measurement revealed a substantial increase in plasma membrane Ca 2+ pump activity by cADPR. Interestingly in this connection, the cADPR binding site within cells has been identified as a 140 kDa protein , a molecular mass similar to that of the plasma membrane Ca 2+ pump (140 kDa) (Schatzmann, 1989) .
By modulating Ca 2+ pump activity on the SR (Lukyanenko et al., 2001 ) and plasma membrane (present study), the effects of cADPR and its antagonists on Ca 2+ homeostasis and the responses to drugs and neurotransmitters would vary depending on the major Ca 2+ source necessary for the response (i.e. SR or extracellular). For example, if the SR was the major source then the antagonist would reduce and the agonist (cADPR) enhance the response (each by modulating the SR Ca 2+ content) (Lukyanenko et al., 2001) ; if external Ca 2+ was the major source, the antagonist could enhance, have no effect on or reduce the response, depending on the balance of effects of the compound on influx (inhibited) and removal (inhibited). By modulating Ca 2+ removal rather than RyR directly, cADPR may have important effects on Ca 2+ regulation and provide an explanation for the diverse effects of cADPR and its antagonists on Ca 2+ homeostasis.
